Oppenheimer sees a merger arbitrage opportunity in Seagen
By Senad Karaahmetovic Oppenheimer analysts reiterated an Outperform rating and a $229 per share price target on Seagen Inc (NASDAQ:SGEN) as the Pfizer (NYSE:PFE) deal spread offers an...
-
-
Oppenheimer maintains Seagen at Outperform
An Oppenheimer analyst maintained Seagen (NASDAQ: SGEN) at Outperform and a price target of $229.00. Prior to this rating, Seagen had 4 buy ratings, 15 hold ratings, and 0 sell...
-
Berenberg downgrades Seagen to Hold
A Berenberg analyst downgraded Seagen (NASDAQ: SGEN) from Buy to Hold with a price target of $229.00 from a prior price target of %currency%%price%. Prior to this rating, Seagen had 6 buy...
-
5 biggest deal reports: UBS plans to buy Credit Suisse for $1 billion | Pro Recap
By Davit KirakosyanInvesting.com -- Here is your Pro Recap of 5 head-turning deal dispatches from the past week you may have missed on InvestingPro. Start your free 7-day trial to get this...
-
5 big analyst cuts: Lam Research downgraded at Bernstein | Pro Recap
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest analyst downgrades you may have missed on InvestingPro since yesterday’s close. Start your free 7-day...
-
Stock market today: Dow ends lower as turmoil in banks weighs on sentiment
By Yasin Ebrahim Investing.com – The Dow closed lower Monday, as investors weighed up a sharp drop in Treasury yields amid bets of a less aggressive Federal Reserve and ongoing turmoil in...
-
S&P 500 turns positive after paring losses on bets of less aggressive Fed
By Yasin Ebrahim Investing.com – The S&P 500 pared losses Monday, as investors weighed up a sharp drop in rates amid bets of a less aggressive Federal Reserve and ongoing turmoil in the...
-
Midday movers: First Republic, Illumina, Seagen and more
By Liz Moyer Investing.com -- Stocks are falling as the shutdown of SVB Financial Group (NASDAQ:SIVB) sends shockwaves through the banking sector. Here are the midday movers for March 10. ...
-
Wells Fargo, First Republic and Pfizer fall premarket; Seagen and Boeing rise
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, March 13th. Please refresh for updates. Banking stocks fell sharply amid contagion worries, with Wells Fargo...
-
Bailouts are back, Fed outlook reassessed, Pfizer M&A - what's moving markets
By Geoffrey Smith Investing.com -- Bailouts are back. Tech bros and crypto firms breathe a sigh of relief as the Feds step in to guarantee all of the deposits at Silicon Valley Bank and...
-
Pfizer snaps up Seagen in $43B deal, sees $10B revenue contribution in 2030
By Vlad Schepkov Pfizer (NYSE:PFE) today announced it has entered a definitive merger agreement to acquire Seagen (NASDAQ:SGEN), a cancer medicines maker, as the company aims to...
-
Bailouts are back, Fed outlook reassessed, Pfizer M&A - what's moving markets
By Geoffrey Smith Investing.com -- Bailouts are back. Tech bros and crypto firms breathe a sigh of relief as the Feds step in to guarantee all of the deposits at Silicon Valley Bank and...
-
6 big deal reports: Microsoft-Activision likely to be greenlit by EU | Pro Recap
By Davit KirakosyanInvesting.com -- Here is your Pro Recap of the biggest deal dispatches from the past week you may have missed on InvestingPro. Start your free 7-day trial to get this news...
-
Stock market today: Dow ends higher as bruised growth stocks attract dip buyers
By Yasin Ebrahim Investing.com -- The Dow closed higher Monday, as dip buying in beaten-down growth stocks helped the broader market recover following its worst week of the year. The Dow...
-
S&P 500 climbs as dip buyers pile into growth stocks following recent rout
By Yasin Ebrahim Investing.com -- The S&P 500 climbed Monday, attempting to put its worst week of the year in the rearview mirror as growth stocks including tech were scooped up by dip...
-
Midday movers: Union Pacific, Seagen, FuboTV and more
By Liz Moyer Investing.com -- Stocks were rising on Monday as investors try to put the worst week for stocks since the beginning of the year in their rearview mirror. Here are the midday...
-
U.S. stocks are rising as investors try to brush off last week's losses
By Liz Moyer Investing.com -- U.S. stocks were rising as investors tried to put the worse weekly performance of this year behind them. At 9:45 ET (14:45 GMT), the Dow Jones Industrial...
-
Seagen, Union Pacific and Tesla rise premarket; Pfizer falls
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, February 27th. Please refresh for updates. Seagen (NASDAQ:SGEN) stock rose about 14% after the Wall Street...
-
Buffett blast, Pfizer eyes Seagen, Bund hits 12-year high - what's moving markets
By Geoffrey Smith Investing.com -- Warren Buffett blasts the new buyback tax as Berkshire Hathaway's performance sags under pressure from last year's market volatility. Pfizer is reportedly...
-
Dow futures rise 125 pts; durable goods, pending home sales data due
By Peter Nurse Investing.com -- U.S. stocks are seen opening higher Monday, recovering ground after last week’s losses ahead of the release of a raft of U.S. economic data which should...
-
WSJ: Pfizer in talks with Seagen over purchase worth possibly over $30 billion
By Scott Kanowsky Investing.com -- U.S. drug-making giant Pfizer Inc. (NYSE:PFE) is in early-stage talks to acquire biotech Seagen Inc. (NASDAQ:SGEN) in a deal that may potentially be worth...
-
Seagen extends gains on two analyst upgrades after earnings
By Senad Karaahmetovic Shares of Seagen (NASDAQ:SGEN) are trading 7% higher in pre-market Thursday trading after the company delivered a narrower-than-expected loss and solid revenue...
-
Seagen Tops Q4 EPS, Revenue
Seagen (SGEN) reported Q4 EPS of ($0.50), $0.53 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $528.15 million versus the consensus estimate of $479.84...
-
Seagen earnings beat by $0.23, revenue topped estimates
Investing.com - Seagen (NASDAQ: SGEN) reported fourth quarter EPS of $-0.80, $0.23 better than the analyst estimate of $-1.03. Revenue for the quarter came in at $528.15M versus the...
-
Last week's biggest management and board changes: Kohl's, Biogen, adidas
By Sarina Isaacs and Senad Karaahmetovic Investing.com - Here are the biggest management and board changes from the past week, as first reported on InvestingPro+. Keurig Dr Pepper...
-
2 rumors lighting up trading screens today
By Investing.com Staff Stocks staged an explosive rally on Thursday after the CPI report was cooler than expected, which stoked hopes the Fed will slow the pace of rate increases sooner...
-
Seagen's announcement likely confirms it will remain a standalone company - Raymond James
By Sam Boughedda Raymond James analysts told investors in a note Thursday that Seagen Inc (NASDAQ:SGEN) announcing David Epstein as their new Chief Executive Officer and member of the board...
-
Seagen earnings miss, Revenue beats in Q3
Investing.com - Seagen reported on Thursday third quarter {{erl-13076||earnings that missed analysts' forecasts and revenue that topped expectations. Seagen announced earnings per share of...
-
Seagen Misses Q3 EPS by 8c
Seagen (SGEN) reported Q3 EPS of ($1.03), $0.08 worse than the analyst estimate of ($0.95). Revenue for the quarter came in at $510 million versus the consensus estimate of $459.58...
-
Today's Most Important Upgrades
By Davit Kirakosyan Amgen (NASDAQ:AMGN) shares were up 6% intra-day today after Morgan Stanley upgraded the company to Overweight from Equalweight and raised its price target to $279 from...
-
Seagen Upgraded to Outperform at BMO, Analysts See 'Undervalued Core Business'
By Senad Karaahmetovic BMO analysts upgraded shares of Seagen (NASDAQ:SGEN) to Outperform from Market Perform with the price target raised by $1 to $178 per share. Analysts believe SGEN’s...
-
Seagen Stock Drops on Report Talks with Merck are Stalling Over Price
By Senad Karaahmetovic Shares of Seagen (NASDAQ:SGEN) are down over 7% after Bloomberg News reported that talks with Merck (NYSE:MRK) are stalling. The two companies have not been able to...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
